{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:07:24Z","timestamp":1783015644400,"version":"3.54.6"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>All pheochromocytomas (PCCs) have metastatic potential, and inoperable cases often resist multidisciplinary treatment. Pheochromocytomas are broadly divided into cluster 1 (hypoxia signaling) and cluster 2 (kinase pathway). Ferroptosis, a regulated form of cell death driven by iron-dependent lipid peroxidation, is induced under hypoxia and may target therapy-resistant malignancies. However, its relevance in PCCs remains entirely unknown. We therefore examined the characteristics of PCCs prone to ferroptosis and evaluated their potential as a therapeutic target.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We performed a retrospective and experimental study to characterize ferroptosis in PCCs and evaluate its clinical significance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We assessed ferroptosis sensitivity and characterized the induction and execution mechanisms in primary cultured cells derived from resected PCCs. The clinical significance of ferroptosis was examined using both 53 PCC tumors and transcriptomic and genetic data from the Gene Expression Omnibus (GEO) database. To investigate the tumor-suppressive function of ferroptosis inducers, a xenograft model was established using PC12 cells treated with dimethyl sulfoxide (DMSO) or ferroptosis inducers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ferroptosis susceptibility varied among PCCs. Ferroptosis-prone cells showed elevated intracellular Fe2+ levels and upregulation of genes involved in Fe2+ accumulation. Analysis of the 53 PCC tumors and GEO data revealed that cases with higher ferroptosis marker expression were more frequently observed in younger patients and were enriched in cluster 1 genotypes. Cluster 1 mutations and hypoxia were associated with transferrin receptor (TFRC) upregulation, enhancing extracellular iron uptake and facilitating ferroptosis. In contrast, cluster 2 tumors relied on ferritinophagy and heme degradation, suggesting reliance on intracellular iron pools. Importantly, ferroptosis inducers markedly reduced tumor volume in xenografts, underscoring their therapeutic potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Exploiting mutation-specific dysregulation of iron metabolism to trigger ferroptosis may provide a novel therapeutic strategy for therapy-resistant pheochromocytomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf248","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:11:01Z","timestamp":1765458661000},"page":"687-699","source":"Crossref","is-referenced-by-count":2,"title":["Hypoxia, iron, and ferroptosis: a novel perspective on pheochromocytoma progression and therapy"],"prefix":"10.1093","volume":"193","author":[{"given":"Yutaro","family":"Ruike","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University , 1-8-1 Inohana, Chuo-ku, Chiba 260-8670 ,","place":["Japan"]},{"name":"Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6774-8070","authenticated-orcid":false,"given":"Sawako","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University , 1-8-1 Inohana, Chuo-ku, Chiba 260-8670 ,","place":["Japan"]},{"name":"Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Graduate School of Medicine, Chiba University , Chiba 260-8670 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Sugo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University , 1-8-1 Inohana, Chuo-ku, Chiba 260-8670 ,","place":["Japan"]},{"name":"Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzuka","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University , 1-8-1 Inohana, Chuo-ku, Chiba 260-8670 ,","place":["Japan"]},{"name":"Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University , 1-8-1 Inohana, Chuo-ku, Chiba 260-8670 ,","place":["Japan"]},{"name":"Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Ishiwata","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University , 1-8-1 Inohana, Chuo-ku, Chiba 260-8670 ,","place":["Japan"]},{"name":"Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University , 1-8-1 Inohana, Chuo-ku, Chiba 260-8670 ,","place":["Japan"]},{"name":"Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University , 1-8-1 Inohana, Chuo-ku, Chiba 260-8670 ,","place":["Japan"]},{"name":"Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University , 1-8-1 Inohana, Chuo-ku, Chiba 260-8670 ,","place":["Japan"]},{"name":"Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Koide","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University , 1-8-1 Inohana, Chuo-ku, Chiba 260-8670 ,","place":["Japan"]},{"name":"Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Imamura","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Chiba University , Chiba 260-8670 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Chiba University , Chiba 260-8670 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Chiba University , Chiba 260-8670 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Biostatistics Section, Clinical Research Center, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Biostatistics Section, Clinical Research Center, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichiro","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Graduate School of Medicine, Chiba University , Chiba 260-8670 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koutaro","family":"Yokote","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University , 1-8-1 Inohana, Chuo-ku, Chiba 260-8670 ,","place":["Japan"]},{"name":"Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital , Chiba 260-8677 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"8","key":"2025121608530100400_lvaf248-B1","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1210\/jc.2008-2697","article-title":"Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy","volume":"94","author":"Nomura","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025121608530100400_lvaf248-B2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11864-020-00787-z","article-title":"Emerging treatments for advanced\/metastatic pheochromocytoma and paraganglioma","volume":"21","author":"Ilanchezhian","year":"2020","journal-title":"Curr Treat Options Oncol"},{"issue":"5","key":"2025121608530100400_lvaf248-B3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/cen.13434","article-title":"Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: a systematic review and meta-analysis","volume":"87","author":"Hamidi","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2025121608530100400_lvaf248-B4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"2","key":"2025121608530100400_lvaf248-B5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","article-title":"Cell death","volume":"187","author":"Newton","year":"2024","journal-title":"Cell"},{"issue":"9","key":"2025121608530100400_lvaf248-B6","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"key":"2025121608530100400_lvaf248-B7","doi-asserted-by":"publisher","first-page":"675617","DOI":"10.3389\/fcell.2021.675617","article-title":"Fatty acids metabolism: the bridge between ferroptosis and ionizing radiation","volume":"9","author":"Yuan","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"2025121608530100400_lvaf248-B8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7784","key":"2025121608530100400_lvaf248-B9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"issue":"14","key":"2025121608530100400_lvaf248-B10","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"3","key":"2025121608530100400_lvaf248-B11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ"},{"issue":"2","key":"2025121608530100400_lvaf248-B12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"4","key":"2025121608530100400_lvaf248-B13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2025121608530100400_lvaf248-B14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2025121608530100400_lvaf248-B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2025121608530100400_lvaf248-B16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41419-020-2385-4","article-title":"Active steroid hormone synthesis renders adrenocortical cells highly susceptible to type II ferroptosis induction","volume":"11","author":"Weigand","year":"2020","journal-title":"Cell Death Dis"},{"issue":"44","key":"2025121608530100400_lvaf248-B17","doi-asserted-by":"publisher","first-page":"22269","DOI":"10.1073\/pnas.1912700116","article-title":"Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis","volume":"116","author":"Belavgeni","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025121608530100400_lvaf248-B18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.humpath.2020.04.012","article-title":"Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting","volume":"110","author":"Thompson","year":"2021","journal-title":"Hum Pathol"},{"issue":"17","key":"2025121608530100400_lvaf248-B19","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/jnci\/djt201","article-title":"Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction","volume":"105","author":"Jochmanov\u00e1","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"3-4","key":"2025121608530100400_lvaf248-B20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000457479","article-title":"Hypoxia pathway mutations in pheochromocytomas and paragangliomas","volume":"150","author":"Amorim-Pires","year":"2017","journal-title":"Cytogenet Genome Res"},{"issue":"21","key":"2025121608530100400_lvaf248-B21","doi-asserted-by":"publisher","first-page":"R1292","DOI":"10.1016\/j.cub.2020.09.068","article-title":"Ferroptosis","volume":"30","author":"Tang","year":"2020","journal-title":"Curr Biol"},{"issue":"10","key":"2025121608530100400_lvaf248-B22","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1210\/jc.2007-0709","article-title":"Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas","volume":"92","author":"Amar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121608530100400_lvaf248-B23","first-page":"378","article-title":"[Etiology and clinical guidelines for the diagnosis and treatment of pheochromocytoma in Japan]","volume":"113","author":"Naruse","year":"2012","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"5","key":"2025121608530100400_lvaf248-B24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/1097-0142(195909\/10)12:5&lt;861::AID-CNCR2820120504&gt;3.0.CO;2-6","article-title":"Histopathology of pheochromocytoma","volume":"12","author":"Sherwin","year":"1959","journal-title":"Cancer"},{"issue":"3","key":"2025121608530100400_lvaf248-B25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2025121608530100400_lvaf248-B26","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.bbrc.2012.04.102","article-title":"Differential dependence on oxygen tension during the maturation process between monomeric Kusabira Orange 2 and monomeric Azami Green expressed in HeLa cells","volume":"421","author":"Kaida","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"2025121608530100400_lvaf248-B27","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1158\/0008-5472.CAN-21-3914","article-title":"GLS2 is a tumor suppressor and a regulator of ferroptosis in hepatocellular carcinoma","volume":"82","author":"Suzuki","year":"2022","journal-title":"Cancer Res"},{"issue":"1","key":"2025121608530100400_lvaf248-B28","doi-asserted-by":"publisher","first-page":"bpy013","DOI":"10.1093\/biomethods\/bpy013","article-title":"Improving the efficiency of gene insertion in a human artificial chromosome vector and its transfer in human-induced pluripotent stem cells","volume":"3","author":"Hasegawa","year":"2018","journal-title":"Biol Methods Protoc"},{"issue":"1","key":"2025121608530100400_lvaf248-B29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","article-title":"iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data","volume":"19","author":"Ge","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"2025121608530100400_lvaf248-B30","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3389\/fnins.2019.01357","article-title":"Temporal changes of spinal transcriptomic profiles in mice with spinal nerve ligation","volume":"13","author":"Yu","year":"2019","journal-title":"Front Neurosci"},{"issue":"14","key":"2025121608530100400_lvaf248-B31","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: an R\/bioconductor package for pathway-based data integration and visualization","volume":"29","author":"Luo","year":"2013","journal-title":"Bioinformatics"},{"issue":"1-2","key":"2025121608530100400_lvaf248-B32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"2025121608530100400_lvaf248-B33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pbiomolbio.2020.04.001","article-title":"Ferroptosis as an emerging target in inflammatory diseases","volume":"155","author":"Mao","year":"2020","journal-title":"Prog Biophys Mol Biol"},{"key":"2025121608530100400_lvaf248-B34","doi-asserted-by":"publisher","first-page":"e02523","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife"},{"issue":"11","key":"2025121608530100400_lvaf248-B35","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1111\/cas.13380","article-title":"Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3","volume":"108","author":"Shintoku","year":"2017","journal-title":"Cancer Sci"},{"issue":"4","key":"2025121608530100400_lvaf248-B36","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3892\/ijo.2019.4720","article-title":"Iron metabolism and its contribution to cancer (Review)","volume":"54","author":"Chen","year":"2019","journal-title":"Int J Oncol"},{"issue":"6","key":"2025121608530100400_lvaf248-B37","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"issue":"12","key":"2025121608530100400_lvaf248-B38","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/tox.22014","article-title":"Cytotoxic, genotoxic, and neurotoxic effects of Mg, Pb, and Fe on pheochromocytoma (PC-12) cells","volume":"30","author":"Sanders","year":"2015","journal-title":"Environ Toxicol"},{"issue":"10","key":"2025121608530100400_lvaf248-B39","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","article-title":"Transferrin receptor is a specific ferroptosis marker","volume":"30","author":"Feng","year":"2020","journal-title":"Cell Rep"},{"key":"2025121608530100400_lvaf248-B40","doi-asserted-by":"publisher","first-page":"127807","DOI":"10.1016\/j.jhazmat.2021.127807","article-title":"Di-(2-ethylhexyl) phthalate exposure leads to ferroptosis via the HIF-1\u03b1\/HO-1 signaling pathway in mouse testes","volume":"426","author":"Wu","year":"2022","journal-title":"J Hazard Mater"},{"issue":"5","key":"2025121608530100400_lvaf248-B41","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3390\/antiox11050921","article-title":"Prospective application of ferroptosis in hypoxic cells for tumor radiotherapy","volume":"11","author":"Su","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"2025121608530100400_lvaf248-B42","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41467-019-09277-9","article-title":"A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis","volume":"10","author":"Zou","year":"2019","journal-title":"Nat Commun"},{"issue":"8","key":"2025121608530100400_lvaf248-B43","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"issue":"7","key":"2025121608530100400_lvaf248-B44","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1007\/s10571-023-01388-8","article-title":"The mechanisms of ferroptosis under hypoxia","volume":"43","author":"Gao","year":"2023","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"2025121608530100400_lvaf248-B45","doi-asserted-by":"publisher","first-page":"e2411380","DOI":"10.1002\/advs.202411380","article-title":"Mesenchymal stem cells prevent SLC39A14-dependent hepatocyte ferroptosis through exosomal miR-16-5p in liver graft","volume":"12","author":"Deng","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"2025121608530100400_lvaf248-B46","doi-asserted-by":"publisher","first-page":"3205040","DOI":"10.1155\/2022\/3205040","article-title":"Downregulated PRNP facilitates cell proliferation and invasion and has effect on the immune regulation in ovarian cancer","volume":"2022","author":"Hu","year":"2022","journal-title":"J Immunol Res"},{"issue":"11","key":"2025121608530100400_lvaf248-B47","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1210\/clinem\/dgac471","article-title":"Targeted therapies in pheochromocytoma and paraganglioma","volume":"107","author":"Wang","year":"2022","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/6\/687\/65919523\/lvaf248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/6\/687\/65919523\/lvaf248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:53:06Z","timestamp":1765893186000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/6\/687\/8381360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf248","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,26]]}}}